PBGH in the News

US needs price controls for COVID-19 drugs, employer advocacy group says

Private employers show new interest in expanded Medicare and regulated drug prices

How Employers Think About Addressing Rising Prices of Health Insurance

Sutter and Calif. AG Revamp Their Search for Antitrust Monitor

The Care Delivery Reckoning: ‘Employers Simply Cannot Afford to Maintain the Status Quo’

How Are Employers Adjusting Health Benefit Strategies Amid the Pandemic?

U.S. Employers Eye Cutting Wasteful Drugs Worth $6 Billion

Many Companies Planned to Reopen Offices After Labor Day. With Coronavirus Still Around, They’re Rethinking That

Sutter Health’s Request to Delay $575 Million Settlement Is Denied